Microba Life Sciences: Trading Update
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Microba Life Sciences Limited has released a trading update ahead of its Annual General Meeting, highlighting record sales for its MetaXplore product and significant milestones in MetaPanel sales. The update indicates strong growth momentum in MetaXplore sales, with figures already surpassing previous periods, and a notable increase in doctor referrals for MetaPanel. Additionally, the UK market is set for growth with an expanded sales team and ongoing efforts towards reimbursement in the USA.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/trading-update-612
Microba Life Sciences Limited on 6ix
In the deck
Earlier from Microba Life Sciences
- Microba receives $6 million R&D Tax Incentive Refund
- Q1 FY25 Quarterly Investor Presentation
- Q1 FY25 Quarterly Activities Report & Appendix 4C
- 2024 Annual Report & Appendix 4E
- Q4 FY24 Quarterly Investor Presentation & Webinar
Later from Microba Life Sciences
- Q2 FY25 Quarterly Activities Report & Appendix 4C
- Q2 FY25 Quarterly Investor Presentation & Webinar
- Appendix 4D & FY25 Interim Report
- Microba Delivers Landmark IBD Results & Signs Major Gastro Partner
- Q3 FY25 Quarterly Activities Report & Appendix 4C
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences